These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32881673)

  • 21. Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study.
    Cho H; Choi KS; Lee JY; Lee D; Choi NK; Lee Y; Bae S
    BMJ Open; 2019 Sep; 9(9):e030930. PubMed ID: 31542758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to comment on: Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema.
    Mohan S; Chawla G; Surya J; Raman R
    Indian J Ophthalmol; 2022 Jun; 70(6):2209. PubMed ID: 35648027
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term follow-up of antivascular endothelial growth factor treatment for diabetic macular oedema: a four-year real-world study.
    Granstam E; Rosenblad A; Modher Raghib A; Granström T; Eriksson JW; Lindholm Olinder A; Leksell J
    Acta Ophthalmol; 2020 Jun; 98(4):360-367. PubMed ID: 31656056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema.
    Bahrami B; Hong T; Zhu M; Schlub TE; Chang A
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1133-1140. PubMed ID: 28238195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor and diabetic macular edema.
    Lally DR; Shah CP; Heier JS
    Surv Ophthalmol; 2016; 61(6):759-768. PubMed ID: 27045225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravitreal Ranibizumab in Diabetic Macular Edema: Long-Term Outcomes.
    Zucchiatti I; Bandello F
    Dev Ophthalmol; 2017; 60():63-70. PubMed ID: 28427066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of clinical studies and recommendation for a therapeutic flow chart for diabetic macular edema.
    Yoshida S; Murakami T; Nozaki M; Suzuma K; Baba T; Hirano T; Sawada O; Sugimoto M; Takamura Y; Tsuiki E
    Graefes Arch Clin Exp Ophthalmol; 2021 Apr; 259(4):815-836. PubMed ID: 32997288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complications of Intravitreous Injections in Patients with Diabetes.
    Gupta A; Sun JK; Silva PS
    Semin Ophthalmol; 2018; 33(1):42-50. PubMed ID: 29420143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema.
    Mohamed QA; Fletcher EC; Buckle M
    BMJ Clin Evid; 2016 Mar; 2016():. PubMed ID: 27031563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
    Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
    Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current and Future Pharmacologic Therapies for Diabetic Retinopathy.
    Villegas VM; Schwartz SG
    Curr Pharm Des; 2018; 24(41):4903-4910. PubMed ID: 30706803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the New "SAVE" Protocol in Diabetic Macular Edema Over the Course of Anti-VEGF Treatment.
    Reznicek L; Bolz M; Garip A; Kampik A; Kernt M; Mayer WJ
    Curr Eye Res; 2016 Aug; 41(8):1082-1086. PubMed ID: 26580417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.
    Bressler SB; Qin H; Melia M; Bressler NM; Beck RW; Chan CK; Grover S; Miller DG;
    JAMA Ophthalmol; 2013 Aug; 131(8):1033-40. PubMed ID: 23807371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema: A Subanalysis of the RESTORE (Extension) Study.
    Karst SG; Deak GG; Gerendas BS; Waldstein SM; Lammer J; Simader C; Guerin T; Schmidt-Erfurth UM
    JAMA Ophthalmol; 2018 Apr; 136(4):315-321. PubMed ID: 29494727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical ketorolac as an adjunctive treatment with intravitreal bevacizumab in the management of diabetic macular edema: A double-masked placebo-controlled randomized clinical trial.
    Nikkhah H; Niazpour Moez R; Entezari M; Ramezani A; Hassanpour K; Karimi S; Yaseri M
    Graefes Arch Clin Exp Ophthalmol; 2021 Oct; 259(10):2949-2959. PubMed ID: 33856549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-VEGF Therapy for Diabetic Eye Diseases.
    Bahrami B; Hong T; Gilles MC; Chang A
    Asia Pac J Ophthalmol (Phila); 2017; 6(6):535-545. PubMed ID: 29076303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population.
    Kumar A; Sinha S
    Indian J Ophthalmol; 2007; 55(6):451-5. PubMed ID: 17951903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT.
    Ozsaygili C; Duru N
    Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal Bevacizumab in Diabetic Retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 Knobloch Lecture.
    Arevalo JF; Liu TYA;
    Asia Pac J Ophthalmol (Phila); 2018; 7(1):36-39. PubMed ID: 29280367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema.
    Vaz-Pereira S; Castro-de-Sousa JP; Martins D; Prates Canelas J; Reis P; Sampaio A; Urbano H; Kaku P; Nascimento J; Marques-Neves C
    Ophthalmic Res; 2020; 63(2):114-121. PubMed ID: 31801148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.